Unibest 优贝德
← Back to patent-cliff list

CAS 74-11-3

4-Carboxychlorobenzene4-chlorobenzoic acid

Codes:(II)461018-33-a、VISM-009、DABI-028

Application context (from source-drug indications)

华氏巨球蛋白血症伊布替尼慢性淋巴细胞白血病伊布替尼套细胞淋巴瘤伊布替尼移植物抗宿主病伊布替尼基底细胞癌维莫地吉多发性骨髓瘤维莫地吉淋巴瘤维莫地吉实体瘤维莫地吉血液肿瘤维莫地吉间质软骨肉瘤维莫地吉静脉血栓栓塞达比加群酯甲磺酸盐栓塞达比加群酯甲磺酸盐中风达比加群酯甲磺酸盐缺血性卒中达比加群酯甲磺酸盐肺栓塞达比加群酯甲磺酸盐静脉血栓形成达比加群酯甲磺酸盐

Source drugs (routes using this intermediate)

DrugTierExpiry
伊布替尼IbrutinibTier A — Act now2027
维莫地吉VismodegibTier C — Watch / trade-
达比加群酯甲磺酸盐Dabigatran Etexilate MesylateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Qualified Partner — East China API WorksDabigatran etexilate mesylate
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Siteethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like SiteN-(4-cyanophenyl)-Glycine
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.